Native Mass Spectrometry: A New High-Throughput Platform for the Identification of Functional Hits

• Native mass spectrometry (MS) has been developed into a robust, high-throughput screening platform which provides a unique dataset for hit identification and prioritisation
• In combination with complimentary MS approaches, rapid identification of functional compounds can be performed
• Medicinal chemistry campaigns can be initiated from a more informed start-point, accelerating future compound design and optimisation

Speakers:

Jonathan Hopper

Vice President, Platforms and Founder

OMass Therapeutics